Prediction of occult neck metastases in laryngeal carcinoma: Role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination

Clinical Cancer Research

Volumn 2, Issue 10, 1996, Pages 1801-1808

  Franchi, Alessandro ^a   Gallo, Oreste ^a   Boddi, Vieri ^a   Santucci, Marco ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; ONCOPROTEIN; PROTEIN P53; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NECK METASTASIS; PRIORITY JOURNAL; PROGNOSIS;

ANTIGENS, NUCLEAR; CADHERINS; CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029907607     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Bocca, E., Calearo, C., De Vincentiis, I., Marullo, T., Motta, G., and Ottaviani, A. Occult metastases in cancer of the larynx and their relationship to clinical and histological aspects of the primary tumor: a four-year multicentric research. Laryngoscope, 94: 1086-1090, 1984.
2. Van den Brekel, M. W. M, Casteljins, J. A., Croll, G. A., Stel, H. V., Valk, J., Van der Waal, I., Golding, R. P., Meyer, C. J. L. M., and Snow, G. B. Magnetic resonance imaging vs palpation of cervical lymph node metastases. Arch. Otolaryngol. Head & Neck Surg., 117: 666-673, 1991.
3. Gallo, O., Boddi, V., Bottai, G. V., Parrella, F., and Fini Storchi, O. The treatment of the clinically negative neck in laryngeal cancer patients. Head Neck, in press, 1996.
4. Shah, J. T., Medina, J. E., Shaha, A. R., Schantz, S. T., and Marti, J. R. Cervical lymph node metastasis. Curr. Probl. Surg., 30: 273-344, 1993.
5. Friedman, M., Mafee, M. F., Pacella, B. L. Strorigl, T. L., Dew, L. L., and Toriumi, D. M. Rationale for elective neck dissection in 1990. Laryngoscope, 100: 54-59, 1990.
6. Ah, S., Tiwan, R. M., and Snow, G. B. False positive and false negative neck nodes. Head Neck Surg., 8: 78-82, 1985.
7. McGavran, M. H., Bauer, W. C., and Ogura, J. K. The incidence of cervical lymph node metastases from epidermoid carcinoma of the larynx and their relationship to certain characteristics of the primary tumor. Cancer (Phila.), 14: 55-66, 1960.
8. Geelen, G. P., Hordijck, G. J., Ravasz, L. A., and Terhaard, C. H. Degree of tumor differentiation as a prognostic factor in advanced laryngeal cancer. Acta Otorhinolaryngol. Belg., 49: 1-4, 1995.
9. Kowalski, L. P., Franco, E. L., and De Andrade Sobrinho, J. Factors influencing regional lymph node metastasis from laryngeal carcinoma. Ann. Otol. Rhinol & Laryngol., 104: 442-447, 1995.
10. Ghouri, A., Zamora, R. L., Session, D. G., Spitznagel, E L., and Harvey, J E. Prediction of occult neck disease in laryngeal cancer by means of a logistic regression statistical model. Laryngoscope, 104: 1280-1284, 1994.
11. Chauvel, P., Courdi, A., Gioanni, J., Vallicioni, J., Santini, J., and Demard, F. The labelling index: a prognostic factor in head and neck carcinoma. Radiother. Oncol., 14: 231-237, 1989.
12. Benazzo, M., Mevio, E., Occhini, A., Franchini, G., and Danova, M. Proliferative characteristics of head and neck tumors: in vivo evaluation by bromodeoxyuridine incorporation and flow cytometry. ORL J. Otorhinolaryngol. Relat. Spec., 57: 39-43, 1995.
13. Wolf, G. T., Fisher, S. G., Truelson, J. M., and Beals, T. F. DNA content and regional metastases in patients with advanced laryngeal squamous cell carcinoma. Laryngoscope, 104: 479-483, 1994.
14. Schipper, J. H., Frixen, U. H., Behrens, J., Unger, A., Jahnke, K., and Birchmeier, W. E-cadherin expression in squamous cell carcinomas of head and neck: inverse correlation with tumor differentiation and lymph node metastasis. Cancer Res., 51: 6328-6337, 1991.
15. Mattijssen, V., Peters, H. M., Schalkwijk, L., Manni, J. J., Van't Hof-Grootenboer, B., De Mulder P. H. M., and Ruiter, D. J. E-cadherin expression in head and neck squamous-cell carcinoma is associated with clinical outcome. Int. J. Cancer, 55: 580-585, 1993.
16. Field, J. K., Spandidos, D. A., Yiagnisis, M., Gosney, J. R., Papadimitriou, K., and Stell, P. M. C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res., 12: 613-620, 1992.
17. Field, J. K., Pavelic, Z. P., Spandidos, D. A., Stambrook, P. J., Jones, A. S., and Gluckman, J. L. The role of the p53 tumor suppressor gene in squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 119: 1118-1122, 1993.
18. Maestro, R., Dolcetti, D., Gasparotto, D., Doglioni, C., Pelucchi, S., Barzan, L., Grandi, E., and Boiocchi, M. High frequency of p53 gene alterations associated with protein over-expression in human squamous cell carcinoma of the larynx. Oncogene, 7: 1159-1166, 1992.
19. Ebina, M., Steinberg, S. M., Mulshine, J. L., and Linnoila, R. I. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer. Cancer Res., 54: 2496-2503, 1994.
20. Kay, E W., Barry Walsh, C. J., Cassidy, M., Curran, B., and Leader, M. C-erbB-2 immunostaining: problems with interpretation. J. Clin. Pathol., 47: 816-822, 1994.
21. Cuevas, E. C., Bateman, A. C., Wilkins, B. S., Johnson, P. A., Williams, J. H., Lee, A. H. S., Jones, D. B., and Wright, B. H. Microwave antigen retrieval in immunocytochemistry: a study of 80 antibodies. J. Clin. Pathol., 47: 448-452, 1994.
22. Moll, R., Mitze, M., Frixen, U. H., and Birchmeier, W. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am. J. Pathol., 143: 1731-1742, 1993.
23. Pignatelli, M., Ansari, T. Q., Gunter, P., Liu, D., Hirano, S., Takeichi, M., Klöppel, G., and Lemoine, N. Loss of membranous E-cadherin expression in pancreatic cancer. correlation with lymph node metastasis, high grade, and advanced stage. J. Pathol., 174: 243-248, 1994.
24. Golick, M. L., and Rice, M. Optimum staining of PCNA in paraffin sections is dependent on fixation, drying, and intensification. J. Histotechnol., 15: 39-41, 1992.
25. Rose, D. S. C., Maddox, P. H., and Brown, D. C. Which proliferation markers for routine immunohistology? A comparison of five antibodies. J. Clin. Pathol., 47: 1010-1014, 1994.
26. Baisch, H., and Gerdes, J. Simultaneous staining of exponentially growing versus plateau phase cells with the proliferation-associated antibody Ki67 and propidium iodide: analysis by flow cytometry. Cell Tissue Kinet., 20: 387-391, 1987.
27. Kamel, O. W., LeBrun, D. P., Davis, R. E., Berry, G. J., and Warnke, R. A. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/cyclin 19A2. Correlation with Ki67 labelling. Am. J. Pathol., 138: 1471-1477, 1991.
28. Oya, M , Yao, T., Nagai, E., and Tsuneyoshi, M. Metastasizing intramucosal gastric carcinomas. Well differentiated type and proliferative activity using proliferative cell nuclear antigen and Ki-67. Cancer (Phila.), 75: 926-935, 1995.
29. Czader, M., Porwit, A., Tani, E., Öst, Å., Mazur, J., and Auer, G. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki-67) in non-Hodgkin's lymphomas. Mod. Pathol., 8: 51-58, 1995.
30. Albers, P., Miller, G. A., Orazi, A., Ulbright, T. M., Albers, J., Donohue, J P., and Foster, R. S. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis. Cancer (Phila.), 75: 844-850, 1995.
31. Tomasino, R. M., Daniele, E., Bazan, V., Morello, V., Tralongo, V., Nuara, R., Nagar, C., Salvato, M., Ingria, F., Restico, S., Dardanoni, G., Vecchione, A., and Russo, A. Prognostic significance of cell kinetics in laryngeal squamous cell carcinoma: clinicopathological associations. Cancer Res., 55: 6103-6108, 1995.
32. Munck-Wikland, E., Edström, S., Jungmark, E., Kuylesteerna, R., Lindholm, J., and Auer, G. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA), and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int. J. Cancer, 56: 95-99, 1994.
33. Shin, D. M., Voravud, N., Ro, J. Y., Lee, J. S., Hong, W. K., and Hittelman, W. N. Sequential increases in proliferating cell nuclear antigen expression in head and neck tumorigenesis: a potential biomarker. J. Natl. Cancer Inst., 85: 971-978, 1993.
34. Resnick, J. M., Uhlman, D., Niehans, G. A., Gapany, M., Adams, G., Knapp, D., and Jaszcz, W. Cervical lymph node status and survival in laryngeal carcinoma: prognostic factors. Ann. Otol. Rhinol. & Laryngol., 104: 685-694, 1995.
35. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M., and Abe, O. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res., 49: 2128-2133, 1989.
36. Pignatelli, M. E-cadherin: a biological marker of tumour differentiation. J. Pathol., 171: 81-82, 1993.
37. Pignatelli, M., Ansari, T. Q., Gunter, P., Liu, D., Shinji, H., Takeichi, M., Klöppel, G., and Lemoine, N. R. Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J. Pathol., 174: 243-248, 1994.
38. Rasbridge, S. A., Gillett, C. E., Sampson, S. A., Walsh, F. S., and Millis, R. R. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J. Pathol., 169: 245-250, 1993.
39. Gagliardi, G., Kandemir, O., Liu, D., Guida, M., Benvestito, S., Ruers, T. G. M., Benjamin, I. S., Northover, J. M. A., Stamp, G. W. H., Talbot, I. C., and Pignatelli, M. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel. Virchows Archiv., 426: 149-154, 1995.
40. Southgate, J., Hutton, K. A. R., Thomas, D. F. M., and Trejdosiewicz, L. K. Normal human urothelial cells in vitro: proliferation and induction of stratification. Lab. Invest., 71: 583-594, 1994.
41. Revillion, F., Vandewalle, B., Hornez, L., and Lefebvre, J. Influence of cAMP on E-cadherin expression and cell surface heparan sulfate proteoglycan synthesis in human breast cancer cells. Anticancer Res., 13: 1625-1630, 1993.
42. Sacchi, T., Bani, D., Brandi, M. L., Falchetti, A., and Bigazzi, M. Relaxin influences growth, differentiation, and cell-cell adhesion of human breast-cancer cells in culture. Int. J. Cancer, 57: 129-134, 1994.
43. Dolcetti, R., Doglioni, C., Maestro, R., Gasparotto, D., Barzan, L., Pastore, A., Romanelli, M., and Boiocchi, M. p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer, 52: 178-182, 1992.
44. Anwar, K., Nakakuki, K., Imai, H., Naiki, H., and Inuzuka, M. Overexpression of p53 protein in human laryngeal carcinoma. Int. J. Cancer, 53: 952-956, 1993.
45. Nadal, A., Campo, E., Pinto, J., Mallofrè, C., Palacìn, A., Arias, C., Traserra, J., and Cardesa, A. p53 expression in normal, dysplastic, and neoplastic laryngeal epithelium: absence of a correlation with prognostic factors. J. Pathol., 175: 181-188, 1995.
46. Baatenburg de Jong, R. J., Knegt, P., and Verwoerd, C. D. A. Reduction of the number of neck treatments in patients with head and neck cancer. Cancer (Phila.), 71: 2312-2318, 1993.